ZA992106B - Statin-MMP inhibitor combinations. - Google Patents

Statin-MMP inhibitor combinations.

Info

Publication number
ZA992106B
ZA992106B ZA9902106A ZA992106A ZA992106B ZA 992106 B ZA992106 B ZA 992106B ZA 9902106 A ZA9902106 A ZA 9902106A ZA 992106 A ZA992106 A ZA 992106A ZA 992106 B ZA992106 B ZA 992106B
Authority
ZA
South Africa
Prior art keywords
statin
mmp inhibitor
inhibitor combinations
combinations
mmp
Prior art date
Application number
ZA9902106A
Inventor
Roger Schofield Newton
Bruce David Roth
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA992106B publication Critical patent/ZA992106B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
ZA9902106A 1998-03-17 1999-03-16 Statin-MMP inhibitor combinations. ZA992106B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7826598P 1998-03-17 1998-03-17

Publications (1)

Publication Number Publication Date
ZA992106B true ZA992106B (en) 1999-09-30

Family

ID=22142950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902106A ZA992106B (en) 1998-03-17 1999-03-16 Statin-MMP inhibitor combinations.

Country Status (18)

Country Link
EP (1) EP1063991A1 (en)
JP (1) JP2002506818A (en)
KR (1) KR20010041916A (en)
AR (1) AR018113A1 (en)
AU (1) AU1591699A (en)
BR (1) BR9815745A (en)
CA (1) CA2309588A1 (en)
CO (1) CO5070670A1 (en)
GT (1) GT199900039A (en)
HN (1) HN1999000029A (en)
MY (1) MY140504A (en)
NZ (1) NZ505994A (en)
PA (1) PA8469001A1 (en)
PE (1) PE20000348A1 (en)
SV (1) SV1999000026A (en)
UY (1) UY25436A1 (en)
WO (1) WO1999047138A1 (en)
ZA (1) ZA992106B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
BRPI0519919A2 (en) 2004-12-15 2009-04-07 Solvay Pharm Gmbh pharmaceutical compositions comprising nep inhibitors, endogenous endothelin production system inhibitors and hmg coa reductase inhibitors
JP2009514851A (en) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド (3R, 5R) -7- [2- (4-Fluorophenyl) -5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino) carbonyl] -pyrrol-1-yl] -3,5 -Preparation of dihydroxy-heptanoic acid hemi-calcium salt
WO2010005389A1 (en) * 2008-07-11 2010-01-14 Forskarpatent I Syd Ab Oxidized ldl specific antibody-fusion and conjugated proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0858336B1 (en) * 1995-11-02 2006-12-20 Warner-Lambert Company Llc Method and pharmaceutical composition for regulating lipid concentration
SK282863B6 (en) * 1996-05-17 2002-12-03 Warner-Lambert Company Biphenylsulfonamide matrix metalloproteinase inhibitors
IL128545A0 (en) * 1996-12-09 2000-01-31 Warner Lambert Co Method for treating and preventing heart failure and ventricular dilatation
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
GT199800126A (en) * 1997-08-29 2000-01-29 COMBINATION THERAPY.

Also Published As

Publication number Publication date
GT199900039A (en) 2000-09-06
CA2309588A1 (en) 1999-09-23
EP1063991A1 (en) 2001-01-03
NZ505994A (en) 2003-10-31
SV1999000026A (en) 2000-01-18
JP2002506818A (en) 2002-03-05
WO1999047138A1 (en) 1999-09-23
KR20010041916A (en) 2001-05-25
PE20000348A1 (en) 2000-05-22
MY140504A (en) 2009-12-31
PA8469001A1 (en) 2002-09-17
AU1591699A (en) 1999-10-11
CO5070670A1 (en) 2001-08-28
BR9815745A (en) 2000-11-14
HN1999000029A (en) 1999-09-29
UY25436A1 (en) 2001-10-25
AR018113A1 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
EG24814A (en) Novel compounds.
HK1036101A1 (en) Refrigerator.
HK1040253A1 (en) Factor viia inhibitors.
ZA99254B (en) Benzosulfone derivatives.
ZA991975B (en) Enzyme inhibitors.
HK1022000A1 (en) Iron.
ZA991272B (en) Novel thiobenzamides.
ZA9811794B (en) Ace inhibitor-MMP inhibitor combinations.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA991550B (en) Cyclohexanediole derivatives.
ZA992572B (en) Spirit chiller.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA200007405B (en) Angiogenesis inhibitors.
ZA992899B (en) Novel compound.
HK1021879A1 (en) Carrying case.
ZA992106B (en) Statin-MMP inhibitor combinations.
ZA994289B (en) Cyclooxygenase inhibitor.
HK1028588A1 (en) Case.
ZA99985B (en) New compound.
ZA99925B (en) Composition.
HK1062445A1 (en) B-secretase inhibitor.
ZA991761B (en) New agent.